Characterising the Network-Specific Effects of Piriform Cortex Stimulation Via SEEG
1 other identifier
interventional
10
1 country
1
Brief Summary
The prospective study aims to characterize the network-specific modulatory effects of piriform cortex stimulation in patients undergoing stereotactic EEG for drug-resistant epilepsy. Using multimodal data, it seeks to link stimulation-evoked electrophysiological responses across brain networks with clinical outcomes, to inform targeted neuromodulation therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2025
CompletedStudy Start
First participant enrolled
December 8, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 8, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 8, 2027
December 26, 2025
December 1, 2025
1.1 years
December 2, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seizure Discharge Suppression Rate
Quantified as the percentage reduction in the frequency of spikes and interictal epileptiform discharges (IEDs) during active stimulation compared to the baseline period.
72 hours
Secondary Outcomes (7)
Single-Pulse Stimulation Amplitude:
72 hours
N1 Component Amplitude and Latency:
72 hours
Spatial Distribution of Activation
72 hours
Effective Connectivity Change:
72 hours
Phase-Amplitude Coupling Index
72 hours
- +2 more secondary outcomes
Study Arms (1)
SEEG recordings and SPES effects
EXPERIMENTALThis arm encompasses patients with drug-resistant focal epilepsy who underwent intracranial monitoring via stereotactically implanted depth electrodes (SEEG) as part of their standard presurgical evaluation. During the monitoring period, these patients additionally underwent systematic Single-Pulse Electrical Stimulation (SPES) mapping. SPES was administered according to a standardized clinical protocol, involving the delivery of single, low-intensity electrical pulses to selected electrode contacts-including those located within or adjacent to the piriform cortex-while recording the evoked electrophysiological responses across the implanted SEEG network. The data collected in this arm include continuous intracranial EEG recordings, precise stimulation parameters (location, intensity), and the corresponding electrophysiological responses used to characterize cortico-cortical evoked potentials and network connectivity.
Interventions
The intervention involves single-pulse electrical stimulation (SPES) applied during stereotactic electroencephalography (SEEG) monitoring. Low-intensity, standardized electrical pulses are delivered to targeted contacts within or near the piriform cortex via implanted depth electrodes, while simultaneous full-bandwidth SEEG recordings capture network-wide electrophysiological responses, allowing characterization of stimulation-evoked brain network activation and modulation patterns.
Eligibility Criteria
You may qualify if:
- The patients were diagnosed with drug-resistant epilepsy.
- The patients underwent stereoelectroencephalography (SEEG) implantation for pre-surgical evaluation of epilepsy, with at least one electrode target reaching the piriform cortex
You may not qualify if:
- Subjects that experience surgical complications during the implant procedure will be excluded from the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xuanwu Hospital
Beijing, Beijing Municipality, 100053, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liankun Ren
Xuanwu Hospital, Beijing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
December 2, 2025
First Posted
December 26, 2025
Study Start
December 8, 2025
Primary Completion (Estimated)
January 8, 2027
Study Completion (Estimated)
November 8, 2027
Last Updated
December 26, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share